RE:RE:Phase 3 run up vs ETA for 3b "Lastly I look forward to the closure of the Vantive sale or spinoff so that Spectral can finally begin interacting with our true partner, which hopefully will include Private Equity. July basically begins that window of when it will be finalized, but it's anybodies guess when it will be completed since Baxter has been very tight lipped about it. Though they do have some very large bonds coming due in Novemeber and also into the foreseable future, so they have all the incentive in the world to finalize the sale of Vantive as quickly as possible." - BJ
"The parties had entered exclusive negotiations in late June, the person said, adding that a deal could be announced in the coming weeks...." -Reuters
But of course the talks between this particular PE Firm and Baxter could still break down.
In 2016 there was only discussion of possible FDA approval. No formal distribution deal, no approved pumps or existing infrastructure for HA commercialization, no fast-tracked device approval process in place with the FDA, and no visibility on who an ultimate buyer of the NA rights might be.
The only similarity seems to be that only a tiny fraction of the investment public is aware of this $2+ Billion USD play, incubating quietly, off- the-radar, in Canada.
MM